IDEAYA Biosciences (IDYA) Free Cash Flow (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Free Cash Flow of -$76.1 million for Q1 2026, down 24.82% on a YoY basis from -$101.3 million in Q1 2025, and up 17.45% sequentially from -$92.2 million in Q4 2025.
IDEAYA Biosciences (IDYA) Free Cash Flow (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Free Cash Flow data on file, last reported at -$76.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 24.82% year-over-year to -$76.1 million; the trailing twelve-month figure through Mar 2026 stood at -$88.6 million (up 66.55% YoY), and the FY2025 full-year result was -$73.5 million, up 70.5% from the prior year.
- Free Cash Flow advanced to -$76.1 million in Q1 2026, from -$92.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $143.6 million in Q3 2025 to a low of -$121.9 million in Q4 2024.
- A 5-year average of -$35.5 million and a median of -$33.3 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 395.63% in 2024 and jumped 397.79% in 2025, its largest moves.
- Tracing IDYA's Free Cash Flow over 5 years: stood at -$20.3 million in 2022, then decreased by 21.05% to -$24.6 million in 2023, then slumped by 395.63% to -$121.9 million in 2024, then increased by 24.31% to -$92.2 million in 2025, then gained by 17.45% to -$76.1 million in 2026.
- Business Quant data shows IDYA's Free Cash Flow at -$76.1 million in Q1 2026, -$92.2 million in Q4 2025, and $143.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -76.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.14 Mn |
| Mar 31, 2026 | -76.14 Mn |
| Dec 31, 2025 | -92.24 Mn |
| Dec 31, 2025 | -92.24 Mn |
| Sep 30, 2025 | 143.58 Mn |
| Sep 30, 2025 | 143.58 Mn |
| Jun 30, 2025 | -63.81 Mn |
| Jun 30, 2025 | -63.81 Mn |
| Mar 31, 2025 | -61.00 Mn |
| Mar 31, 2025 | -61.00 Mn |
| Dec 31, 2024 | -121.86 Mn |
| Dec 31, 2024 | -121.86 Mn |
| Sep 30, 2024 | -48.21 Mn |
| Sep 30, 2024 | -48.21 Mn |
| Jun 30, 2024 | -33.86 Mn |
| Jun 30, 2024 | -33.86 Mn |
| Mar 31, 2024 | -45.14 Mn |
| Mar 31, 2024 | -45.14 Mn |
| Dec 31, 2023 | -24.59 Mn |
| Dec 31, 2023 | -24.59 Mn |